Advertisement
Berita Forex
Malaysia Shares May Take Further Damage On Wednesday
The Malaysia stock market has finished lower in back-to-back sessions, slipping almost 5 points or 0.3 percent in that span. The Kuala Lumpur Composite Index now sits just shy of the 1,455-point plateau and the losses may accelerate on Wednesday.
RTTNews |
579 hari yang lalu
Tech Shares Likely To Drag KOSPI Lower
The South Korea stock market has climbed higher in four straight sessions, advancing more than 70 points or 2.7 percent along the way. The KOSPI now rests just shy of the 2,670-point plateau and investors are likely to cash in on Wednesday.
RTTNews
|
579 hari yang lalu
New Zealand Money Supply Data Due On Wednesday
New Zealand will on Wednesday see November numbers for its M3 money supply, highlighting a very light day for Asia-Pacific economic activity.
RTTNews
|
579 hari yang lalu
U.S. Dollar Starts New Year On Upbeat Note
Following a disappointing final month of 2023, the value of the U.S. dollar showed a strong move to the upside to start the new year. The advance by the dollar may reflect its appeal a safe haven, as Middle East tensions escalated after U.S. helicopters repelled an attack on Sunday by Iran-backed Houthi militants on a Maersk container vessel in the Red Sea.
RTTNews
|
579 hari yang lalu
European Markets Finish Mixed And Little Changed
The major European markets were unable to hold onto early gains on Tuesday, giving ground as the day progressed to finish mixed and fairly flat.
RTTNews
|
579 hari yang lalu
U.S. Construction Spending Climbs Slightly Less Than Expected In November
A report released by the Commerce Department on Tuesday showed construction spending in the U.S. rose by slightly less than expected in November, although the report also showed a significant upward revision to the increase in spending in October.
RTTNews
|
579 hari yang lalu
Allorion Therapeutic Inks Agreement With AstraZeneca For EGFR L858R Allosteric Inhibitor Program
Allorion Therapeutics, a US and China-based biotechnology company, on Tuesday entered into an exclusive option and global license agreement with British drug major AstraZeneca plc (AZN) to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor, as a potential new treatment for advanced EGFR-mutant non-small cell lung cancer (NSCLC).
RTTNews
|
580 hari yang lalu
more news
Pound Drops As U.K. Manufacturing Downturn Intensifies
The pound weakened against its major counterparts in the European session on Tuesday, as the nation's manufacturing activity contracted at a faster pace in December as output fell sharply amid weaker demand conditions both domestically and internationally.
RTTNews
|
580 hari yang lalu
Biora Therapeutics Says BioJet Systemic Oral Delivery Platform Met Key Performance Milestones
Biotech company Biora Therapeutics, Inc. (BIOR) announced Tuesday that its BioJet Systemic Oral Delivery Platform has met key performance milestones as part of its research collaboration with British drug major AstraZeneca plc (AZN.L, AZN).
RTTNews
|
580 hari yang lalu
Comfort Systems USA To Acquire Summit Industrial Construction For Undisclosed Terms
Comfort Systems USA, Inc. (FIX) announced Tuesday that it has entered into a definitive agreement to acquire Houston, Texas-based Summit Industrial Construction, LLC. The transaction is currently expected to close in the first quarter of 2024.
RTTNews
|
580 hari yang lalu
Alimera Sciences Names Elliot Maltz To Succeed Russell Skibsted As CFO
Pharmaceutical company Alimera Sciences, Inc. (ALIM) announced Tuesday that Elliot Maltz has been named Chief Financial Officer effective immediately.
RTTNews
|
580 hari yang lalu
H World Group Names Jun Zou To Succeed Jihong He As New CFO
Hotel operator H World Group Ltd. (HTHT) announced that Jihong He will step down as the chief financial officer of the Company and serve as the chief strategy officer of the Company, effective from January 2, 2024.
RTTNews
|
580 hari yang lalu
Theratechnologies Files SBLA For Trogarzo Intramuscular Method Of Administration With FDA
Biopharmaceutical company Theratechnologies Inc. (THTX, TH.TO) announced Tuesday the filing of a supplemental Biologics License Application (sBLA) for an intramuscular (IM) method of administration for the maintenance dose of Trogarzo (ibalizumab-uiyk) to the U.S. Food and Drug Administration (FDA) for review.
RTTNews
|
580 hari yang lalu
Stay up to date!
Add Berita to your browser
Add To Chrome
